CalciMedica (CALC) Other Accumulated Expenses (2019 - 2026)
CalciMedica's (CALC) quarterly Other Accumulated Expenses came in at $672000.0 in Q1 2026, down 44.6% YoY from $1.2 million in Q1 2025, and up 131.72% on a QoQ basis from $290000.0 in Q4 2025.
CalciMedica (CALC) Other Accumulated Expenses (2019 - 2026) Analysis & Trends
CalciMedica (CALC) has 8 years of Other Accumulated Expenses data on file, last reported at $672000.0 in Q1 2026.
- Quarterly Other Accumulated Expenses fell 44.6% year-over-year to $672000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $672000.0 (down 44.6% YoY) and the FY2025 annual result came in at $290000.0, down 66.51% from the prior year.
- Other Accumulated Expenses climbed to $672000.0 in Q1 2026, from $290000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $2.8 million in Q3 2022 to a low of $290000.0 in Q4 2025.
- A 5-year average of $1.3 million and a median of $1.1 million in 2023 frame the typical range for Other Accumulated Expenses.
- Annual changes were most pronounced in 2022 — Other Accumulated Expenses plunged 82.27% — and 2023, when it jumped 156.64%.
- Tracing CALC's Other Accumulated Expenses over 5 years: stood at $572000.0 in 2022, then surged by 156.64% to $1.5 million in 2023, then sank by 41.01% to $866000.0 in 2024, then slumped by 66.51% to $290000.0 in 2025, then jumped by 131.72% to $672000.0 in 2026.
- The last three Other Accumulated Expenses figures came in at $672000.0 (Q1 2026), $290000.0 (Q4 2025), and $1.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | CalciMedica | 9.80 Mn | -8.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.22 Mn |
| Mar 31, 2026 | 672,000.00 |
| Dec 31, 2025 | 290,000.00 |
| Sep 30, 2025 | 1.03 Mn |
| Jun 30, 2025 | 895,000.00 |
| Mar 31, 2025 | 1.21 Mn |
| Dec 31, 2024 | 866,000.00 |
| Sep 30, 2024 | 1.14 Mn |
| Jun 30, 2024 | 941,000.00 |
| Mar 31, 2024 | 1.75 Mn |
| Dec 31, 2023 | 1.47 Mn |
| Jun 30, 2023 | 1.07 Mn |
| Mar 31, 2023 | 1.47 Mn |
| Dec 31, 2022 | 572,000.00 |
| Sep 30, 2022 | 2.76 Mn |
| Jun 30, 2022 | 2.46 Mn |
| Mar 31, 2022 | 2.28 Mn |
| Dec 31, 2021 | 3.23 Mn |
| Sep 30, 2021 | 2.16 Mn |
| Jun 30, 2021 | 1.64 Mn |